Advertisement

Picture Kentro Design Is Key to Your Success Berlin 650x100px
Organisation › Details

Bico (Group)

Founded in 2016, BICO (formerly CELLINK) is the leading bio convergence company in the world. By combining different technologies, such as robotics, artificial intelligence, computer science, and 3D bioprinting with biology, we enable our customers to improve people's health and lives for the better. With a focus on the application areas of bioprinting, multiomics, cell line development, and diagnostics, the company develops and markets innovative technologies that enable researchers in the life sciences to culture cells in 3D, perform high-throughput drug screening and print human tissues and organs for the medical, pharmaceutical, and cosmetic industries. We create the future of health. The Group’s products are trusted by more than 2,000 laboratories, including all the top 20 pharmaceutical companies, are being used in more than 65 countries, and have been cited in more than 1,850 publications. BICO is listed on Nasdaq Stockholm under BICO. *

 

Period Start 2021-08-12 renamed
Products Industry 3D bioprinting
  Industry 2 single cell dispenser
Persons Person Forss, Maria (Bico Group 202311– CEO before Vitrolife + AstraZeneca)
  Person 2 Thordenberg, Jacob (Bico 202205 Head of M&A)
     
Region Region Göteborg (Gothenburg)
  Country Sweden
  City n. a. 
    Address record changed: 2021-09-23
     
Basic data Employees D: 101 to 500 (2019-08-31)
  Currency SEK
  Annual sales 105,457,000 (sales, net, consolidated (2018/19) 2019-08-31)
  Profit 581,000 (2019-08-31)
  Cash 198,770,000 (2019-08-31)
     
    * Document for »About Section«: Bico Group AB. (8/23/21). "Press Release: Dispendix Welcomes Petros Apostolopoulos as New CEO to Strengthen Position as Leading Liquid Handling and Lab Automation Company".
     
   
Record changed: 2024-02-12

Advertisement

Picture EBD Group World of Partnering Opportunities 650x200px

More documents for Bico (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

Picture EBD Group World of Partnering Opportunities 650x300px




» top